The global high flow nasal cannula market size was USD 6.66 billion in 2023, estimated at USD 7.39 billion in 2024 and is anticipated to reach around USD 20.27 billion by 2034, expanding at a CAGR of 10.62% from 2024 to 2034.
Chapter 1. Introduction
1.1. Research Objective
1.2. Scope of the Study
1.3. Definition
Chapter 2. Research Methodology
2.1. Research Approach
2.2. Data Product Types
2.3. Assumptions& Limitations
Chapter 3. Executive Summary
3.1. Market Snapshot
Chapter 4. High Flow Nasal Cannula Market Variables and Scope
4.1. Introduction
4.2. Market Classification and Scope
Chapter 5. COVID 19 Impact on High Flow Nasal Cannula Market
5.1. Covid-19: High Flow Nasal Cannula Industry Impact
5.2. High Flow Nasal Cannula Business Impact Assessment: Covid-19
5.2.1. Services Challenges/Disruption
5.2.2. Market Trends and High Flow Nasal Cannula Opportunities in the COVID-19 Landscape for Major Markets
5.3. Strategic Measures against Covid-19
5.3.1. Government Support and Initiative to Combat Covid-19
5.3.2. Proposal for High Flow Nasal Cannula Market Players to deal with Covid-19 Pandemic Scenario
Chapter 6. High Flow Nasal Cannula Market Dynamics Analysis and Trends
6.1. Market Dynamics
6.1.1. Market Drivers
6.1.1.1. Ever-increasing number of respiratory disorders
6.1.1.2. Low cost of high-flow nasal cannula compared to low-flow oxygen delivery systems
6.1.2. Market Restraints
6.1.2.1. Low rate of adoption of modern healthcare applications in developing countries
6.1.3. Market Opportunities
6.1.3.1. Increasing popularity and uptake of heated humidified high-flow nasal cannulas
Chapter 7. Global High Flow Nasal Cannula Market: Competitive Landscape
7.1.1. Company Market Share/Positioning Analysis
7.1.1.1. High Flow Nasal Cannula Market Revenue by Market Players
7.1.1.2. High Flow Nasal Cannula Market Revenue Market Share by Market Players
7.1.2. Key Organic/Inorganic Strategies Adopted by Players
7.1.2.1. Product Portfolio, Expansion, Geographic Expansion, Product Innovation
7.1.2.2. Merger and Acquisition, Collaboration and Partnerships
7.1.3. Market Players Landscape
7.1.3.1. List of Suppliers
7.1.3.2. List of End user
Chapter 8. Global High Flow Nasal Cannula Market, By Product Type
8.1. High Flow Nasal Cannula Market, by Product Type, 2024-2034
8.1.1. Single Heated Tube
8.1.1.1. Market Revenue and Forecast (2021-2034)
8.1.2. Nasal cannula
8.1.2.1. Market Revenue and Forecast (2021-2034)
8.1.3. Active humidifier
8.1.3.1. Market Revenue and Forecast (2021-2034)
8.1.4. Air blender
8.1.4.1. Market Revenue and Forecast (2021-2034)
Chapter 9. Global High Flow Nasal Cannula Market, By End-user
9.1. High Flow Nasal Cannula Market, by End-user, 2024-2034
9.1.1. Hospitals and clinics
9.1.1.1. Market Revenue and Forecast (2021-2034)
9.1.2. Ambulatory care centers
9.1.2.1. Market Revenue and Forecast (2021-2034)
9.1.3. Long-term care centers
9.1.3.1. Market Revenue and Forecast (2021-2034)
9.1.4. Others
9.1.4.1. Market Revenue and Forecast (2021-2034)
Chapter 10. Global High Flow Nasal Cannula Market, By Application
10.1. High Flow Nasal Cannula Market, by Application, 2024-2034
10.1.1. Acute Respiratory Disorder
10.1.1.1. Market Revenue and Forecast (2021-2034)
10.1.2. Chronic Respiratory Disorder
10.1.2.1. Market Revenue and Forecast (2021-2034)
10.1.3. Acute Heart Failures
10.1.3.1. Market Revenue and Forecast (2021-2034)
10.1.4. Others
10.1.4.1. Market Revenue and Forecast (2021-2034)
Chapter 11. Global High Flow Nasal Cannula Market, By Sales Channel
11.1. High Flow Nasal Cannula Market, by Sales Channel, 2024-2034
11.1.1. Direct Channel
11.1.1.1. Market Revenue and Forecast (2021-2034)
11.1.2. Distribution Channel
11.1.2.1. Market Revenue and Forecast (2021-2034)
Chapter 12. Global High Flow Nasal Cannula Market, Regional Estimates and Trend Forecast
12.1. North America
12.1.1. Market Revenue Forecast by Product Type(2021-2034)
12.1.2. Market Revenue Forecast by End-user (2021-2034)
12.1.3. Market Revenue Forecast by Application (2021-2034)
12.1.4. Market Revenue Forecast by Sales Channel (2021-2034)
12.1.5. U.S
12.1.5.1. Market Revenue Forecast (2021-2034)
12.1.6. Canada
12.1.6.1. Market Revenue Forecast (2021-2034)
12.2. Europe
12.2.1. Market Revenue Forecast by Product Type (2021-2034)
12.2.2. Market Revenue Forecast by End-user (2021-2034)
12.2.3. Market Revenue Forecast by Application (2021-2034)
12.2.4. Market Revenue Forecast by Sales Channel (2021-2034)
12.2.5. UK
12.2.5.1. Market Revenue Forecast (2021-2034)
12.2.6. Germany
12.2.6.1. Market Revenue Forecast (2021-2034)
12.2.7. France
12.2.7.1. Market Revenue Forecast (2021-2034)
12.2.8. Rest of EU
12.2.8.1. Market Revenue Forecast (2021-2034)
12.3. Asia Pacific (APAC)
12.3.1. Market Revenue Forecast by Product Type (2021-2034)
12.3.2. Market Revenue Forecast by End-user (2021-2034)
12.3.3. Market Revenue Forecast by Application (2021-2034)
12.3.4. Market Revenue Forecast by Sales Channel (2021-2034)
12.3.5. China
12.3.5.1. Market Revenue Forecast (2021-2034)
12.3.6. India
12.3.6.1. Market Revenue Forecast (2021-2034)
12.3.7. Japan
12.3.7.1. Market Revenue Forecast (2021-2034)
12.3.8. Rest of APAC
12.3.8.1. Market Revenue Forecast (2021-2034)
12.4. LATAM
12.4.1. Market Revenue Forecast by Product Type (2021-2034)
12.4.2. Market Revenue Forecast by End-user (2021-2034)
12.4.3. Market Revenue Forecast by Application (2021-2034)
12.4.4. Market Revenue Forecast by Sales Channel (2021-2034)
12.4.5. Brazil
12.4.5.1. Market Revenue Forecast (2021-2034)
12.4.6. Rest of LATAM
12.4.6.1. Market Revenue Forecast (2021-2034)
12.5. Middle East and Africa (MEA)
12.5.1. Market Revenue Forecast by Product Type (2021-2034)
12.5.2. Market Revenue Forecast by End-user (2021-2034)
12.5.3. Market Revenue Forecast by Application (2021-2034)
12.5.4. Market Revenue Forecast by Sales Channel (2021-2034)
12.5.5. GCC
12.5.5.1. Market Revenue Forecast (2021-2034)
12.5.6. North Africa
12.5.6.1. Market Revenue Forecast (2021-2034)
12.5.7. South Africa
12.5.7.1. Market Revenue Forecast (2021-2034)
12.5.8. Rest of MEA
12.5.8.1. Market Revenue Forecast (2021-2034)
Chapter 13. Company Profiles
13.1. Armstrong Medical Ltd
13.1.1. Company Overview, Business Information, Regional Presence
13.1.2. Product Portfolio, Analysis
13.1.2.1. Product Details, Specification, Application
13.1.3. Revenue, Price, and Gross Margin
13.1.4. Recent Developments and Strategies
13.2. Becton Dickinson, and Company
13.2.1. Company Overview, Business Information, Regional Presence
13.2.2. Product Portfolio, Analysis
13.2.2.1. Product Details, Specification, Application
13.2.3. Revenue, Price, and Gross Margin
13.2.4. Recent Developments and Strategies
13.3. Fisher & Paykel Healthcare Limited
13.3.1. Company Overview, Business Information, Regional Presence
13.3.2. Product Portfolio, Analysis
13.3.2.1. Product Details, Specification, Application
13.3.3. Revenue, Price, and Gross Margin
13.3.4. Recent Developments and Strategies
13.4. Flexicare Medical Ltd
13.4.1. Company Overview, Business Information, Regional Presence
13.4.2. Product Portfolio, Analysis
13.4.2.1. Product Details, Specification, Application
13.4.3. Revenue, Price, and Gross Margin
13.4.4. Recent Developments and Strategies
13.5. Hamilton Medical AG
13.5.1. Company Overview, Business Information, Regional Presence
13.5.2. Product Portfolio, Analysis
13.5.2.1. Product Details, Specification, Application
13.5.3. Revenue, Price, and Gross Margin
13.5.4. Recent Developments and Strategies
13.6. ResMed, Inc.
13.6.1. Company Overview, Business Information, Regional Presence
13.6.2. Product Portfolio, Analysis
13.6.2.1. Product Details, Specification, Application
13.6.3. Revenue, Price, and Gross Margin
13.6.4. Recent Developments and Strategies
13.7. Salter Labs Inc
13.7.1. Company Overview, Business Information, Regional Presence
13.7.2. Product Portfolio, Analysis
13.7.2.1. Product Details, Specification, Application
13.7.3. Revenue, Price, and Gross Margin
13.7.4. Recent Developments and Strategies
13.8. Smiths Medical
13.8.1. Company Overview, Business Information, Regional Presence
13.8.2. Product Portfolio, Analysis
13.8.2.1. Product Details, Specification, Application
13.8.3. Revenue, Price, and Gross Margin
13.8.4. Recent Developments and Strategies
13.9. Teijin Pharma Limited.
13.9.1. Company Overview, Business Information, Regional Presence
13.9.2. Product Portfolio, Analysis
13.9.2.1. Product Details, Specification, Application
13.9.3. Revenue, Price, and Gross Margin
13.9.4. Recent Developments and Strategies
13.10. Teleflex Inc
13.10.1. Company Overview, Business Information, Regional Presence
13.10.2. Product Portfolio, Analysis
13.10.2.1. Product Details, Specification, Application
13.10.3. Revenue, Price, and Gross Margin
13.10.4. Recent Developments and Strategies
13.11. TNI Medical AG
13.11.1. Company Overview, Business Information, Regional Presence
13.11.2. Product Portfolio, Analysis
13.11.2.1. Product Details, Specification, Application
13.11.3. Revenue, Price, and Gross Margin
13.11.4. Recent Developments and Strategies
13.12. Vapotherm Inc.
13.12.1. Company Overview, Business Information, Regional Presence
13.12.2. Product Portfolio, Analysis
13.12.2.1. Product Details, Specification, Application
13.12.3. Revenue, Price, and Gross Margin
13.12.4. Recent Developments and Strategies
Chapter 14. Appendix
14.1. About Us
14.2. Glossary of Terms
No cookie-cutter, only authentic analysis – take the 1st step to become a Precedence Research client
Get a Sample